The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS)

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease.
• Genetic mutations in familial ALS often affect RNA processing pathways.
• Perturbed RNA metabolism is increasingly recognized as a key factor in neurodegeneration.

Purpose of the Study:

• To review the role of aberrant RNA metabolism in the pathogenesis of ALS.
• To examine the link between genetic mutations and RNA processing defects in ALS.
• To explore the potential of targeting RNA metabolism for ALS therapies.

Main Methods:

• Review of existing literature on genetic mutations in ALS.
• Analysis of the impact of mutations on RNA metabolism processes.
• Examination of the role of RNA-binding proteins and protein aggregates in ALS.

Main Results:

• A majority of familial ALS genetic mutations directly impact RNA transcription, splicing, transport, translation, or degradation.
• Dysfunctional RNA-binding proteins are linked to reduced neurofilament light (NFL) mRNA levels in ALS motor neurons.
• Proteins forming cytosolic aggregates in ALS (mtSOD1, TDP-43, 14-3-3) can alter NFL mRNA stability.

Conclusions:

• ALS can be conceptualized as a disorder of RNA metabolism.
• Alterations in mRNA-binding factor interactions are central to ALS pathogenesis.
• Targeting RNA metabolism pathways presents a novel therapeutic strategy for ALS.